Anticardiolipin Antibodies
Important
Note
If
tests show that you suffer from any of these abnormalities /
dysfunctions, you can view the treatment options available and
discuss them with your own
medical doctor or consultant. These
treatments can only be undertaken with the permission and
supervision of your own medical doctor
- The following is taken from a research paper on the subject Hokama et al. (1). "As a possible autoimmune disease, CFS patients may
be treated by suppression of the ACA or by diminishing the antigen CL in serum. Previous studies have shown that treatment with monoclonal antibodies to B cells reduces ACA levels to normal in patients with autoimmune disease, leading to clinical improvements. Specifically, Rituximab, a chimeric monoclonal CD20 antibody, has been shown to normalize high ACA serum titers of patients with autoimmune systemic lupus erythematosus, rheumatoid arthritis, autoimmune thrombocytopenia, and autoimmune hemolytic anemia. Rituximab may serve as an effective therapeutic agent for ameliorating the symptoms of CFS". (1)
- Re-designating old medical drugs for CFS Treatment
CFIDS Association of America has got Biovista ( http://biovista.com ) in the USA to engage in research and data mining of thousands of medical drugs (including some which are currently out of use) and find matches between them and the symptoms, abnormalities and dysfunctions found in ME. They are compiling a list of these medical drugs. Safety guidelines, side effects, clinical reports and general efficacy and other factors will also be taken into account for each medical drug
- Stress Reduction
In addition to getting medical treatment for immune system, krebs cycle and methylation cycle dysfunctions, infections and other biological abnormalities and dysfunctions one should also get Stress Reduction treatment as all physical illnesses including Cancer, AIDS, ME, Multiple Sclerosis, Fibromyalgia, autoimmune illness, Cardiac related illnesses, advanced Diabetes, etc. causes great stress for patients. Click here for Stress Reduction treatment
Research articles & Clinical Findings
1. Anticardiolipin Antibodies in the Sera of Patients with Diagnosed Chronic Fatigue Syndrome Yoshitsugi Hokama, Cara Empey Campora, Cynthia Hara, Tina Kuribayashi, Diana Le Huynh, and Kenichi Yabusaki. Department of Pathology, John A. Burns School of Medicine, University of Hawaii at Maˆnoa, Honolulu, Hawaii. Journal of Clinical Laboratory Analysis 23 : 210–212 (2009). |